IFP Advisors’s Solid Biosciences SLDB Stock Holding History

IFP Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98K	Hold	298	–	–	﹤0.01%	4058
2026 Q1	$2.15K	Hold	298	–	–	﹤0.01%	3936
2025 Q4	$1.68K	Hold	298	–	–	﹤0.01%	3899
2025 Q3	$1.84K	Hold	298	–	–	﹤0.01%	3731
2025 Q2	$1.45K	Buy	298 +290	+3,625%	+$1.02K	﹤0.01%	4041
2025 Q1	$30	Hold	8	–	–	﹤0.01%	4114
2024 Q4	$32	Buy	+8	New	+$44	﹤0.01%	4369

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IFP Advisors's SLDB Position: Q2 2026 in Review

IFP Advisors held its Solid Biosciences (SLDB) position steady in Q2 2026 at 298 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4058.

IFP Advisors first reported a position in SLDB in Q4 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

IFP Advisors held 298 shares of Solid Biosciences worth $2.98K as of Q2 2026.
IFP Advisors left its Solid Biosciences share count unchanged in Q2 2026.
Solid Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4058 holding.
IFP Advisors first reported a position in Solid Biosciences in Q4 2024 and has held it in 7 quarters since.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.